4basebio PLC (AIM:4BB)
London · Delayed Price · Currency is GBP · Price in GBX 550.00
0.00 (0.00%)
Aug 14, 2026, 4:35 PM GMT
4basebio Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -16.91 | -12.33 | -7.67 | -5.15 | -3.24 |
Depreciation & Amortization | 1.03 | 0.89 | 0.71 | 0.42 | 0.25 |
Other Amortization | 0.11 | 0.05 | 0 | 0.01 | 0.07 |
Stock-Based Compensation | 0.29 | 0.33 | - | - | - |
Other Operating Activities | 0.9 | -0.3 | 0.39 | -0.15 | -0.28 |
Change in Accounts Receivable | -0.29 | -0.08 | -0.11 | 0.14 | -0.13 |
Change in Inventory | -0.28 | -0.05 | -0.2 | 0.03 | -0.03 |
Change in Accounts Payable | -0.44 | 0.75 | 0.7 | -0 | 0.62 |
Operating Cash Flow | -15.59 | -10.74 | -6.18 | -4.7 | -2.74 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.47 | -0.7 | -0.87 | -1.16 | -0.88 |
Sale (Purchase) of Intangibles | -1.17 | -0.87 | -0.62 | -0.79 | -0.63 |
Other Investing Activities | 0.91 | 0.07 | - | - | - |
Investing Cash Flow | -0.73 | -1.5 | -1.49 | -1.94 | -1.51 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 8.8 | 6.58 | 1.41 | - |
Total Debt Issued | - | 8.8 | 6.58 | 1.41 | - |
Long-Term Debt Repaid | -0.4 | -4.1 | -0.09 | -0.08 | -0.39 |
Total Debt Repaid | -0.4 | -4.1 | -0.09 | -0.08 | -0.39 |
Net Debt Issued (Repaid) | -0.4 | 4.7 | 6.49 | 1.34 | -0.39 |
Issuance of Common Stock | 0.03 | 39.18 | 0 | - | - |
Other Financing Activities | -0.07 | -0.09 | -0.07 | -0.09 | -0.08 |
Financing Cash Flow | -0.44 | 43.8 | 6.43 | 1.24 | -0.47 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.04 | -0.02 | -0.04 | 0.17 | -0.7 |
Net Cash Flow | -16.8 | 31.54 | -1.28 | -5.24 | -5.42 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -16.06 | -11.44 | -7.05 | -5.86 | -3.62 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -948.49% | -1226.26% | -1393.08% | -2186.19% | -1072.19% |
Free Cash Flow Per Share | -1.03 | -0.87 | -0.57 | -0.48 | -0.29 |
Levered Free Cash Flow | -12.15 | -7.92 | -5.48 | -5.45 | -3.23 |
Unlevered Free Cash Flow | -11.6 | -7.45 | -5.29 | -5.39 | -3.16 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.07 | 0.09 | 0.07 | 0.09 | 0.08 |
Cash Income Tax Paid | -0.41 | -0.12 | -0.56 | -0.4 | - |
Change in Working Capital | -1.01 | 0.62 | 0.38 | 0.17 | 0.46 |